title: Consistent global approach on reporting of colistin doses to promote safe and effective use.
authors.affiliation: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
authors.forename: Roger L
authors.initials: RL
authors.lastname: Nation
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.forename: Otto
authors.initials: O
authors.lastname: Cars
authors.forename: William
authors.initials: W
authors.lastname: Couet
authors.forename: Michael N
authors.initials: MN
authors.lastname: Dudley
authors.forename: Keith S
authors.initials: KS
authors.lastname: Kaye
authors.forename: Johan W
authors.initials: JW
authors.lastname: Mouton
authors.forename: David L
authors.initials: DL
authors.lastname: Paterson
authors.forename: Vincent H
authors.initials: VH
authors.lastname: Tam
authors.forename: Ursula
authors.initials: U
authors.lastname: Theuretzbacher
authors.forename: Brian T
authors.initials: BT
authors.lastname: Tsuji
authors.forename: John D
authors.initials: JD
authors.lastname: Turnidge
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D003091:Colistin / Q000008:administration & dosage* / Q000009:adverse effects*; D014943:Global Health; D006801:Humans; D012107:Research Design
chemical_list: D000900:Anti-Bacterial Agents; D003091:Colistin